Related references
Note: Only part of the references are listed.NDRG2 suppresses cell proliferation through down-regulation of AP-1 activity in human colon carcinoma cells
Young Jun Kim et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Functional and clinical evidence for NDRG2 as a candidate suppressor of liver cancer metastasis
Dong Chul Lee et al.
CANCER RESEARCH (2008)
Role of Akt/GSK-3β/β-catenin transduction pathway in the muscle anti-atrophy action of insulin-like growth factor-I in glucocorticoid-treated rats
O. Schakman et al.
ENDOCRINOLOGY (2008)
Expression of NDRG2 is down-regulated in high-risk adenomas and colorectal carcinoma
Anders Lorentzen et al.
BMC CANCER (2007)
Promoter methylation, mutation, and genomic deletion are involved in the decreased NDRG2 expression levels in several cancer cell lines
Na Liu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
The effect of pleiotrophin signaling on adipogenesis
Dayong Gu et al.
FEBS LETTERS (2007)
The repression of human differentiation-related gene NDRG2 expression by Myc via miz-1-dependent interaction with the NDRG2 core promoter
Jian Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
The metastasis suppressor, Ndrg-1: a new ally in the fight against cancer
Zaklina Kovacevic et al.
CARCINOGENESIS (2006)
Up-regulation of CYP26A1 in adenomatous polyposis coli-deficient vertebrates via a WNT-dependent mechanism: Implications for intestinal cell differentiation and colon tumor development
Dawne N. Shelton et al.
CANCER RESEARCH (2006)
Repression of HIP/RPL29 expression induces differentiation in colon cancer cells
JJ Liu et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2006)
Ndrg2 promotes neurite outgrowth of NGF-differentiated PC12 cells
K Takahashi et al.
NEUROSCIENCE LETTERS (2005)
Integrative genomic analysis identifies NDRG2 as a candidate tumor suppressor gene frequently inactivated in clinically aggressive meningioma
EA Lusis et al.
CANCER RESEARCH (2005)
Glucocorticoid regulation of glial responses during hippocampal neurodegeneration and regeneration
NR Nichols et al.
BRAIN RESEARCH REVIEWS (2005)
Akt mediates insulin-stimulated phosphorylation of Ndrg2-: Evidence for cross-talk with protein kinase C θ
JG Burchfield et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Exploitation of KESTREL to identify NDRG family members as physiological substrates for SGK1 and GSK3
JT Murray et al.
BIOCHEMICAL JOURNAL (2004)
NDRG2:: a novel Alzheimer's disease associated protein
C Mitchelmore et al.
NEUROBIOLOGY OF DISEASE (2004)
Expression and regulation of NDRG2 (N-myc downstream regulated gene 2) during the differentiation of dendritic cells
SC Choi et al.
FEBS LETTERS (2003)
N-myc downstream-regulated gene 2 (NDRG2) inhibits glioblastoma cell proliferation
YC Deng et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Multiple Roles of the PI3K/PKB (Akt) Pathway in Cell Cycle Progression
Jiyong Liang et al.
CELL CYCLE (2003)
The ins and outs of APC and β-catenin nuclear transport
BR Henderson et al.
EMBO REPORTS (2002)
Characterization of rat NDRG2 (N-Myc downstream regulated gene 2), a novel early mineralocorticoid-specific induced gene
S Boulkroun et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Control of β-catenin phosphorylation/degradation by a dual-kinase mechanism
CM Liu et al.
CELL (2002)
Id2 is a target of the β-catenin/T cell factor pathway in colon carcinoma
SP Rockman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Regulation of GSK-3: A cellular multiprocessor
AJ Harwood
CELL (2001)
The Hedgehog and Wnt signaling pathways in cancer
J Taipale et al.
NATURE (2001)
Linking colorectal cancer to Wnt signaling
M Bienz et al.
CELL (2000)
Cancer - Wnt signaling in oncogenesis and embryogenesis - a look outside the nucleus
M Peifer et al.
SCIENCE (2000)
Control of beta-catenin stability: Reconstitution of the cytoplasmic steps of the wnt pathway in Xenopus egg extracts
A Salic et al.
MOLECULAR CELL (2000)